Anti-proliferative effect of LXR agonist T0901317 in ovarian carcinoma cells

<p>Abstract</p> <p>Background</p> <p>Ovarian cancer is the most common cause of cancer related death from gynecologic tumors in the United States. The insidious nature of the disease precludes early diagnosis, therefore surgical debulking and chemotherapy are considered...

Full description

Bibliographic Details
Main Authors: Rough James J, Monroy M Alexandra, Yerrum Smitha, Daly John M
Format: Article
Language:English
Published: BMC 2010-05-01
Series:Journal of Ovarian Research
Online Access:http://www.ovarianresearch.com/content/3/1/13